REPLACE COVID Trial: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Can Be Safely Continued in Patients Admitted to Hospital With COVID-19
A recent trial by Dr. Jordana B Cohen, published in The LANCET, indicated that…
Study Shows Emergent Percutaneous Coronary Intervention in Patients with Unstable Coronary Plaque Improves the Survival After Sudden Cardiac Arrest
The emergent percutaneous coronary intervention (PCI) of unstable plaques, compared to stable…
Study Shows Aortic Valve Replacement Was Associated With Better Outcomes in Patients with Low-Gradient Aortic Stenosis and Preserved Left Ventricular Ejection Fraction Compared With High-Gradient Aortic Stenosis
A recent study by Dr. Salaun, published in Circulation: Cardiovascular Interventions, demonstrated…
DAPA-HF Trial: Compared to Placebo, Dapagliflozin Was Beneficial in Patients with Heart Failure and Reduced Ejection Fraction Regardless of Background Diuretic Therapy
A recent study by Dr. Alice M. Jackson M.D., published in Circulation…
Cohort Study Showed a Large Number of Patients Receiving Anticancer Therapy Demonstrate Myocardial Injury or Left Ventricular Dysfunction, With Only Few Showing Severe Cardiotoxicity
A recent study by Dr. Lopez-Sendon, published in European Heart Journal, showed…
Trial Showed Implementation of High Sensitivity Cardiac Troponin Assays and Universal Definition of Myocardial Infarction Recommendations in Patients with Suspected Acute Coronary Syndrome Increased Diagnosis Rate Without a Change in Outcomes
A recent study by Dr. Chapman, published in Circulation, showed that implementation…
Elevated Coronary Sinus Neuropeptide Y Levels Are Associated With Adverse Outcomes in Patients With Chronic Heart Failure
The study by Dr. Ajijola, published in JAMA Cardiology, found that elevated…
The Sarcomeric Human Cardiomyopathy Registry: Race Associated with Disease Expression and Clinical Outcomes Among Patients with Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited genetic disorder of the…
GALILEO-4D: Rivaroxaban-Aspirin Based Anti-Thrombotic Therapy Post-TAVR Protects From Valve Leaflet Motion Abnormalities
An expanded analysis of 231 patients from the GALILEO trial comparing rivaroxaban-aspirin…
New-Onset AF After TAVR linked To Worse Long-Term Outcomes Compared With Patients With Pre-Existing AF and No AF
A registry-based cohort study including 72,660 Medicare patients with and without atrial…
Meta-analysis Shows Reduced 1-Year Mortality with TAVR in Low-Risk Severe AS Patients
In a meta-analysis of RCTs comparing TAVR (Transcatheter Aortic Valve Replacement) versus…
Meta-analysis Shows Vitamin D Supplementation Does Not Improve Cardiovascular Outcomes
In the largest updated meta-analysis study conducted to understand the inverse association…
TAVR Using Balloon Expandable Valve Superior To Surgical Aortic Valve Replacement In Low Risk Patients With Severe Aortic Valve Stenosis
A randomized multi-center trial which enrolled 1000 patients from 71 centers around…
Antithrombotic therapy post TAVR: A double edged sword?
A multicenter, prospective nation-wide French registry evaluated whether oral anticoagulation therapy was…
Discharging Patients Is Safe, the Next Day After Minimalist TAVR
In a recent study published in the Journal of the American College…
Delayed Coronary Obstruction: a post-TAVR Complication
A recently published study in the Journal of American College of Cardiology …
Assessment of Long-term Outcomes in Patients Undergoing SAVR
A contemporary cohort study recently published in Journal of the American College of…
Frailty and Conventional Risk Scores in Patients Undergoing TAVR
The usage of combined risk models of frailty and conventional risk scores…